Biogen Inc. (BIIB) Annual Margin Report - Discounting Cash Flows
BIIB
Biogen Inc.
BIIB (NASDAQ)

Annual Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (Example: Net Income Margin = Net Income / Revenue).

This analysis provides a report of the company's key margins, which could be further used in a valuation model.

Interactive Assumptions

Historical Years

Historical Years

Number of historical years used to render the Chart and Tables.

Margin Analysis (% of Revenue)

Monetary values are in USD

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020
Revenue 10,655 9,816 9,676 9,836 10,173 10,982 13,445
Revenue Growth Rate -5.94% 1.45% -1.62% -3.32% -7.36% -18.32% -6.49%
Cost of Revenue 2,239 2,398 2,310 2,533 2,278 2,110 1,805
Gross Profit 8,416 7,419 7,366 7,302 7,895 8,872 11,639
Gross Margin 78.49% 75.58% 76.12% 74.24% 77.61% 80.79% 86.57%
Operating Income 2,814 2,274 2,219 2,097 2,902 2,841 4,550
Operating Margin 25.94% 23.17% 22.93% 21.32% 28.52% 25.87% 33.84%
Net Income 2,146 1,479 1,632 1,161 3,047 1,556 4,001
Net Margin 19.6% 15.07% 16.87% 11.81% 29.95% 14.17% 29.76%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020
Revenue 10,655 9,816 9,676 9,836 10,173 10,982 13,445
Cash From Operating Activities Margin 25% 26.3% 29.72% 15.73% 13.61% 33.15% 31.46%
Cash From Operating Activities 2,710 2,582 2,876 1,547 1,384 3,640 4,230
Free Cash Flow Margin 22.05% 23.39% 26% 12.56% 11.25% 30.79% 28.3%
Free Cash Flow 2,396 2,296 2,516 1,236 1,144 3,382 3,805
Depreciation and Amortization Margin 5.36% 7.22% 6.96% 5.03% 5.1% 4.44% 3.4%
Depreciation and Amortization 556.7 708.9 673.2 494.8 518.4 487.7 457.2
Capital Expenditure Margin -2.94% -2.91% -3.72% -3.17% -2.36% -2.35% -3.16%
Capital Expenditure -313.4 -286 -359.8 -311.4 -240.3 -258.1 -424.8
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us